A Stenotrophomonas maltophilia strain evades a major Caenorhabditis elegans defense pathway

Infection and Immunity

Volumn 84, Issue 2, 2016, Pages 524-536

  White, Corin V ^a   Darby, Brian J ^a,b   Breeden, Robert J ^a   Herman, Michael A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; INTESTINE DISTENSION; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; ANIMAL; ANIMAL MODEL; BACTERIAL LOAD; GENETICS; IMMUNE EVASION; IMMUNOLOGY; INTESTINE; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MICROBIOLOGY; MUTATION; PATHOGENICITY; SIGNAL TRANSDUCTION;

CAENORHABDITIS ELEGANS PROTEIN; DAF-2 PROTEIN, C ELEGANS; INSULIN RECEPTOR;

ANIMALS; BACTERIAL LOAD; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; IMMUNITY, INNATE; INTESTINES; MICROBIAL VIABILITY; MODELS, ANIMAL; MUTATION; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; STENOTROPHOMONAS MALTOPHILIA;

EID: 84957657339     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00711-15     Document Type: Article

References (62)

1. Denton M, Kerr KG. 1998. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57-80.
2. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV. 2007. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 45: 3352-3359. http://dx.doi.org/10.1128/JCM.01284-07.
3. Garazi M, Singer C, Tai J, Ginocchio CC. 2012. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect 81:114-118. http://dx.doi.org/10.1016/j.jhin.2012.02.008.
4. De Oliveira-Garcia D, Dall'Agnol M, Rosales M, Azzuz ACGS, Alcántara N, Martinez MB, Girón JA. 2003. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 5:625-636. http://dx.doi.org/10.1046/j.1462-5822.2003.00306.x.
5. Steinkamp G, Wiedemann B, Rietschel E, Krahl A, Gielen J, Bärmeier H, Ratjen F. 2005. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros 4:41-48. http://dx.doi.org/10.1016/j.jcf.2004.10.002.
6. Parent K, Mitchell P. 1978. Cell wall-defective variants of Pseudomonaslike (group Va) bacteria in Crohn's disease. Gastroenterology 75:368-372.
7. Parent K, Mitchell PD. 1976. Bacterial variants: etiologic agent in Crohn's disease? Gastroenterology 71:365-368.
8. A'Court C, Garrard CS. 1992. Nosocomial pneumonia in the intensive care unit: mechanisms and significance. Thorax 47:465-473. http://dx.doi.org/10.1136/thx.47.6.465.
9. Brooke JS. 2012. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25:2-41. http://dx.doi.org/10.1128/CMR.00019-11.
10. Ryan RP, Monchy S, Cardinale M, Taghavi S, Crossman L, Avison MB, Berg G, van der Lelie D, Dow JM. 2009. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol 7:514-525. http://dx.doi.org/10.1038/nrmicro2163.
11. Looney WJ, Narita M, Mühlemann K. 2009. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312-323. http://dx.doi.org/10.1016/S1473-3099(09)70083-0.
12. Steinert M. 2011. Pathogen-host interactions in Dictyostelium, Legionella, Mycobacterium and other pathogens. Semin Cell Dev Biol 22:70-76. http://dx.doi.org/10.1016/j.semcdb.2010.11.003.
13. Fouhy Y, Scanlon K, Schouest K, Spillane C, Crossman L, Avison MB, Ryan RP, Dow JM. 2007. Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol 189:4964-4968. http://dx.doi.org/10.1128/JB.00310-07.
14. Irazoqui JE, Ausubel FM. 2010. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Caenorhabditis elegans as a model to study tissues involved in host immunity and microbial pathogenesis. Clin Exp Immunol 160:48-57. http://dx.doi.org/10.1111/j.1365-2249.2010.04122.x.
15. Pujol N, Link EM, Liu LX, Kurz CL, Alloing G, Tan MW, Ray KP, Solari R, Johnson CD, Ewbank JJ. 2001. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr Biol 11:809-821. http://dx.doi.org/10.1016/S0960-9822(01)00241-X.
16. Couillault C, Pujol N, Reboul J, Sabatier L, Guichou J-F, Kohara Y, Ewbank JJ. 2004. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 5:488-494. http://dx.doi.org/10.1038/ni1060.
17. Tenor JL, Aballay A. 2008. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep 9:103-109. http://dx.doi.org/10.1038/sj.embor.7401104.
18. Irazoqui JE, Urbach JM, Ausubel FM. 2010. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev Immunol 10:47-58. http://dx.doi.org/10.1038/nri2689.
19. Tan MW, Shapira M. 2011. Genetic and molecular analysis of nematodemicrobe interactions. Cell Microbiol 13:497-507. http://dx.doi.org/10.1111/j.1462-5822.2011.01570.x.
20. Marsh EK, May RC. 2012. Caenorhabditis elegans, a model organism for investigating immunity. Appl Environ Microbiol 78:2075-2081. http://dx.doi.org/10.1128/AEM.07486-11.
21. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, Tanaka-Hino M, Hisamoto N, Matsumoto K, Tan M-W, Ausubel FM. 2002. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297:623-626. http://dx.doi.org/10.1126/science.1073759.
22. Sifri CD, Begun J, Ausubel FM, Calderwood SB. 2003. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect Immun 71:2208-2217. http://dx.doi.org/10.1128/IAI.71.4.2208-2217.2003.
23. Bischof LJ, Kao C-Y, Los FCO, Gonzalez MR, Shen Z, Briggs SP, van der Goot FG, Aroian RV. 2008. Activation of the unfolded protein response is required for defenses against bacterial pore-forming toxin in vivo. PLoS Pathog 4:e1000176. http://dx.doi.org/10.1371/journal.ppat.1000176.
24. Bravo A, Gill SS, Soberón M. 2007. Mode of action of Bacillus thuringiensis Cry and Cyt toxins and their potential for insect control. Toxicon 49:423-435. http://dx.doi.org/10.1016/j.toxicon.2006.11.022.
25. Zugasti O, Ewbank JJ. 2009. Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat Immunol 10:249-256. http://dx.doi.org/10.1038/ni.1700.
26. Mallo GV, Kurz CL, Couillault C, Pujol N, Granjeaud S, Kohara Y, Ewbank JJ. 2002. Inducible antibacterial defense system in C. elegans. Curr Biol 12:1209-1214. http://dx.doi.org/10.1016/S0960-9822(02)00928-4.
27. Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, Calderwood SB, Ruvkun G, Ausubel FM. 2003. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300:1921. http://dx.doi.org/10.1126/science.1080147.
28. Gems D, Sutton AJ, Sundermeyer ML, Albert PS, King KV, Edgley ML, Larsen PL, Riddle DL. 1998. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150:129-155.
29. Dillin A, Crawford DK, Kenyon C. 2002. Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298:830-834. http://dx.doi.org/10.1126/science.1074240.
30. Huang X, Zhang H, Zhang H. 2011. The zinc-finger protein SEA-2 regulates larval developmental timing and adult lifespan in C. elegans. Development 138:2059-2068. http://dx.doi.org/10.1242/dev.057109.
31. Evans EA, Chen WC, Tan M-W. 2008. The DAF-2 insulin-like signaling pathway independently regulates aging and immunity in C. elegans. Aging Cell 7:879-893. http://dx.doi.org/10.1111/j.1474-9726.2008.00435.x.
32. Alper S, McBride SJ, Lackford B, Freedman JH, Schwartz DA. 2007. Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol Cell Biol 27:5544-5553. http://dx.doi.org/10.1128/MCB.02070-06.
33. Evans EA, Kawli T, Tan M-W. 2008.Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog 44:e1000175. http://dx.doi.org/10.1371/journal.ppat.1000175.
34. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. 2006. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet 2:e183. http://dx.doi.org/10.1371/journal.pgen.0020183.
35. Huang X, Liu J, Ding J, He Q, Xiong R, Zhang K. 2009. The investigation of nematocidal activity in Stenotrophomonas maltophilia G2 and characterization of a novel virulence serine protease. Can J Microbiol 55:934-942 http://dx.doi.org/10.1139/W09-045.
36. Rae R, Riebesell M, Dinkelacker I, Wang Q, Herrmann M, Weller AM, Dieterich C, Sommer RJ. 2008. Isolation of naturally associated bacteria of necromenic Pristionchus nematodes and fitness consequences. J Exp Biol 211:1927-1936. http://dx.doi.org/10.1242/jeb.014944.
37. Ciche TA, Groffredi SK. 2007. General methods to investigate microbial symbioses, p 394-419. In Reddy CA, Beveridge TJ, Breznak JA, Marzluf GA, Schmidt TM, Snyder LR (ed), Methods for general and molecular microbiology, 3rd ed. ASM Press, Washington, DC.
38. Goel MK, Khanna P, Kishore J. 2010. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res 1:274-278. http://dx.doi.org/10.4103/0974-7788.76794.
39. UCLA Statistical Consulting Group. 13 October 2014. Supplemental notes to applied survival analysis. UCLA Statistical Consulting Group, Los Angeles, CA. http://www.ats.ucla.edu/stat/examples/asa/test_proportionality.htm.
40. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, Calderwood SB, Ausubel FM. 2001. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci U S A 98:10892-10897 http://dx.doi.org/10.1073/pnas.191378698.
41. Portal-Celhay C, Bradley ER, Blaser MJ. 2012. Control of intestinal bacterial proliferation in regulation of lifespan in Caenorhabditis elegans. BMC Microbiol 12:49. http://dx.doi.org/10.1186/1471-2180-12-49.
42. Gruber JAN, Tang SY, Halliwell B. 2007. Evidence for a trade-offbetween survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Ann N Y Acad Sci 1100:530-542. http://dx.doi.org/10.1196/annals.1395.059.
43. Twumasi-Boateng K, Shapira M. 2012. Dissociation of immune responses from pathogen colonization supports pattern recognition in C. elegans. PLoS One 7:e35400. http://dx.doi.org/10.1371/journal.pone.0035400.
44. Shapira M, Hamlin BJ, Rong J, Chen K, Ronen M, Tan M-W. 2006. A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci U S A 103:14086-14091. http://dx.doi.org/10.1073/pnas.0603424103.
45. Applied Biosystems. 1997. User bulletin #2: ABI Prism 7700 sequence detection 889 system. Applied Biosystems, Waltham, MA.
46. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
47. Tan MW, Mahajan-Miklos S, Ausubel FM. 1999. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci U S A 96:715-720. http://dx.doi.org/10.1073/pnas.96.2.715.
48. Huang C, Xiong C, Kornfeld K. 2004. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc Natl Acad Sci U S A 101:8084-8089. http://dx.doi.org/10.1073/pnas.0400848101.
49. Sifri CD, Begun J, Ausubel FM. 2005. The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol 13:119-127 http://dx.doi.org/10.1016/j.tim.2005.01.003.
50. Spanier B, Starke M, Higel F, Scherer S, Fuchs TM. 2010. Yersinia enterocolitica infection and tcaA-dependent killing of Caenorhabditis elegans. Appl Environ Microbiol 76:6277-6285. http://dx.doi.org/10.1128/AEM.01274-10.
51. Irazoqui JE, Troemel ER, Feinbaum RL, Luhachack LG, Cezairliyan BO, Ausubel FM. 2010. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog 6:e1000982. http://dx.doi.org/10.1371/journal.ppat.1000982.
52. Hsiao J-Y, Chen C-Y, Yang M-J, Ho H-C. 2013. Live and dead GFPtagged bacteria showed indistinguishable fluorescence in Caenorhabditis elegans gut. J Microbiol 51:367-372. http://dx.doi.org/10.1007/s12275-013-2589-8.
53. Garigan D, Hsu A-L, Fraser AG, Kamath RS, Ahringer J, Kenyon C. 2002 Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics 161:1101-1112.
54. Hsin H, Kenyon C. 1999. Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399:362-366. http://dx.doi.org/10.1038/20694.
55. Miyata S, Begun J, Troemel ER, Ausubel FM. 2008. DAF-16-dependent suppression of immunity during reproduction in Caenorhabditis elegans. Genetics 178:903-918. http://dx.doi.org/10.1534/genetics.107.083923.
56. Kerry S, TeKippe M, Gaddis NC, Aballay A. 2006. GATA transcription factor required for immunity to bacterial and fungal pathogens. PLoS One 1:e77. http://dx.doi.org/10.1371/journal.pone.0000077.
57. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C. 2003. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424:277-283. http://dx.doi.org/10.1038/nature01789.
58. Mahajan-Miklos S, Tan M, Rahme LG, Ausubel FM. 1999. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96:47-56.
59. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.
60. Shivers RP, Kooistra T, Chu SW, Pagano DJ, Kim DH. 2009. Tissuespecific activities of an immune signaling module regulate physiological responses to pathogenic and nutritional bacteria in C. elegans. Cell Host Microbe 6:321-330. http://dx.doi.org/10.1016/j.chom.2009.09.001.
61. Shivers RP, Pagano DJ, Kooistra T, Richardson CE, Reddy KC, Whitney JK, Kamanzi O, Matsumoto K, Hisamoto N, Kim DH. 2010. Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 MAPK regulates innate immunity in Caenorhabditis elegans. PLoS Genet 6:e1000892. http://dx.doi.org/10.1371/journal.pgen.1000892.
62. Richardson CE, Kooistra T, Kim DH. 2010. An essential role for XBP-1 in host protection against immune activation in C. elegans. Nature 463: 1092-1095. http://dx.doi.org/10.1038/nature08762.